N. J. Pagidipati Et Al. , "Secondary Prevention of Cardiovascular Disease in Patients With Type 2 Diabetes Mellitus International Insights From the TECOS Trial (Trial Evaluating Cardiovascular Outcomes With Sitagliptin)," CIRCULATION , vol.136, no.13, pp.1193-1205, 2017
Pagidipati, N. J. Et Al. 2017. Secondary Prevention of Cardiovascular Disease in Patients With Type 2 Diabetes Mellitus International Insights From the TECOS Trial (Trial Evaluating Cardiovascular Outcomes With Sitagliptin). CIRCULATION , vol.136, no.13 , 1193-1205.
Pagidipati, N. J., Navar, A. M., Pieper, K. S., Green, J. B., Bethel, M. A., Armstrong, P. W., ... Josse, R. G.(2017). Secondary Prevention of Cardiovascular Disease in Patients With Type 2 Diabetes Mellitus International Insights From the TECOS Trial (Trial Evaluating Cardiovascular Outcomes With Sitagliptin). CIRCULATION , vol.136, no.13, 1193-1205.
Pagidipati, Neha Et Al. "Secondary Prevention of Cardiovascular Disease in Patients With Type 2 Diabetes Mellitus International Insights From the TECOS Trial (Trial Evaluating Cardiovascular Outcomes With Sitagliptin)," CIRCULATION , vol.136, no.13, 1193-1205, 2017
Pagidipati, Neha J. Et Al. "Secondary Prevention of Cardiovascular Disease in Patients With Type 2 Diabetes Mellitus International Insights From the TECOS Trial (Trial Evaluating Cardiovascular Outcomes With Sitagliptin)." CIRCULATION , vol.136, no.13, pp.1193-1205, 2017
Pagidipati, N. J. Et Al. (2017) . "Secondary Prevention of Cardiovascular Disease in Patients With Type 2 Diabetes Mellitus International Insights From the TECOS Trial (Trial Evaluating Cardiovascular Outcomes With Sitagliptin)." CIRCULATION , vol.136, no.13, pp.1193-1205.
@article{article, author={Neha J. Pagidipati Et Al. }, title={Secondary Prevention of Cardiovascular Disease in Patients With Type 2 Diabetes Mellitus International Insights From the TECOS Trial (Trial Evaluating Cardiovascular Outcomes With Sitagliptin)}, journal={CIRCULATION}, year=2017, pages={1193-1205} }